Beranda1099 • HKG
add
Sinopharm Group Co Ltd
Tutup sebelumnya
$19,80
Rentang hari
$19,60 - $20,00
Rentang tahun
$17,44 - $25,20
Kapitalisasi pasar
61,98 M HKD
Volume Rata-Rata
6,01 jt
Rasio P/E
6,37
Hasil dividen
4,81%
Bursa utama
HKG
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (CNY) | Mar 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 147,27 M | 1,20% |
Biaya operasional | 7,19 M | 3,80% |
Laba bersih | 1,42 M | -10,70% |
Margin laba bersih | 0,96 | -11,93% |
Penghasilan per saham | — | — |
EBITDA | 3,91 M | -13,51% |
Tarif pajak efektif | 23,21% | — |
Neraca
Total aset
Total liabilitas
| (CNY) | Mar 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 48,91 M | 3,62% |
Total aset | 413,07 M | 2,78% |
Total liabilitas | 290,20 M | 0,49% |
Total ekuitas | 122,86 M | — |
Saham yang beredar | 3,12 M | — |
Harga terhadap reservasi | 0,81 | — |
Tingkat pengembalian aset | 2,13% | — |
Pengembalian modal | 4,25% | — |
Arus Kas
Perubahan bersih tunai
| (CNY) | Mar 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | 1,42 M | -10,70% |
Kas dari operasi | -47,48 M | -16,68% |
Tunai dari investasi | 256,12 jt | -38,43% |
Tunai dari pembiayaan | 22,15 M | 4,94% |
Perubahan bersih tunai | -25,07 M | -30,76% |
Arus kas bebas | -24,53 M | -79,75% |
Tentang
Sinopharm Group Co., Ltd. is a Chinese pharmaceutical company. The parent company of Sinopharm Group was Sinopharm Industrial Investment, a 51–49 joint venture of state-owned enterprise China National Pharmaceutical Group and civilian-run enterprise Fosun Pharmaceutical.
Its H shares were listed on the Hong Kong Stock Exchange in 2009, with its IPO price of HK$16 per share. Sinopharm Group's subsidiary Sinopharm CNMC and Sinopharm Accord served as the A share counterpart of the company. However, the A share of Sinopharm Group itself was unlisted.
Sinopharm Group was ranked 829th in 2016 Forbes Global 2000 list. Wikipedia
Didirikan
2003
Situs
Karyawan
115.959
